Clinical trial · Interventional
Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial
NCT06248866CI-TRIAL-00117818ESWTcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
this study will be conducted to investigate the effect of extracorporeal shock wave therapy on ultrasonography chnges In patients with palmar fibromatosis
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Palmar Fibromatosis | Palmar Fibromatosis | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Extracorporeal Shock Wave Therapy | Other | — | UNRESOLVED |
| traditional treatment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Extracorporeal Shock Wave Therapy
- description
- patients will receive Extracorporeal Shock Wave Therapy and traditional treatment three times a week for six weeks
- interventionNames
- Other: Extracorporeal Shock Wave Therapy
- Other: traditional treatment
- type
- ACTIVE_COMPARATOR
- label
- traditional treatment
- description
- patients will receive traditional treatment three times a week for six weeks
- interventionNames
- Other: traditional treatment
Primary outcomes (1)
- measure
- thickness of lesion
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with palmar fibromatosis. * Adults aged 18 to 70 years. * Patients of any stage of physiological change of the disease (nodules cords and contractures). Exclusion Criteria: * Patients with contraindications to extracorporeal shock wave therapy. * Patients with a history of previous surgery for palmar fibromatosis. * Patients with comorbidities or conditions that may affect the outcomes of the study. * Patients of ganglions and palmar tendon fibrosis. * Patients of sever and morbid obesity. * End stage disease with psychological disturbance nature. * Pregnant women. * Cardiac and pulmonary unstable patients may affect results.
References
Publications (0)
Data not yet available
No reference posted for this study.